bf/NASDAQ:NEO_icon.png

NASDAQ:NEO

NeoGenomics, Inc.

  • Stock

USD

Last Close

10.40

06/11 21:54

Market Cap

1.73B

Beta: 1.12

Volume Today

7.04M

Avg: 1.25M

PE Ratio

−18.59

PFCF: −36.57

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.46M
-
3.86M
57.09%
5.68M
47.09%
6.86M
20.83%
8.06M
17.46%
11.53M
42.99%
21.97M
90.55%
26.46M
20.46%
23.84M
9.92%
24.22M
1.60%
average payables
5.24M
-
16.17M
208.94%
27.72M
71.37%
27.73M
0.04%
21.93M
20.92%
33.94M
54.76%
57.73M
70.13%
41.65M
27.86%
50.60M
21.49%
51.81M
2.38%
average receivables
19.56M
-
34.71M
77.41%
52.23M
50.47%
57.97M
10.99%
68.67M
18.46%
85.58M
24.62%
100.54M
17.48%
109.49M
8.90%
115.92M
5.88%
125.47M
8.24%
book value per share
1.13
-
3.93
248.32%
2.41
38.83%
2.59
7.54%
3.74
44.63%
5.05
34.94%
6.39
26.61%
9.24
44.48%
8.03
13.03%
7.50
6.63%
capex per share
-0.07
-
-0.04
48.11%
-0.10
165.57%
-0.17
77.35%
-0.17
3.03%
-0.20
19.27%
-0.27
34.42%
-0.53
99.53%
-0.25
53.49%
-0.23
7.88%
capex to depreciation
-0.67
-
-0.31
53.63%
-0.32
4.70%
-0.61
86.63%
-0.66
8.66%
-0.66
0.48%
-0.81
23.11%
-1.20
47.60%
-0.44
62.99%
-0.40
10.97%
capex to operating cash flow
-0.40
-
-0.35
13.20%
-0.35
1.27%
-0.76
116.31%
-0.32
57.90%
-0.86
168.24%
-19.93
2,225.21%
2.40
112.04%
0.47
80.50%
14.72
3,045.08%
capex to revenue
-0.04
-
-0.02
48.77%
-0.03
39.11%
-0.05
71.46%
-0.05
2.32%
-0.05
5.26%
-0.07
33.63%
-0.13
102.30%
-0.06
54.24%
-0.05
19.81%
cash per share
0.63
-
0.39
38.57%
0.16
58.26%
0.16
0.06%
0.11
29.01%
1.72
1,402.80%
2.73
58.44%
4.30
57.46%
3.53
17.93%
3.31
6.17%
days of inventory on hand
20.60
-
33.27
61.50%
17.07
48.69%
19.73
15.56%
21.12
7.08%
24.80
17.42%
41.68
68.06%
28.73
31.08%
27.53
4.15%
25.41
7.73%
days payables outstanding
49.56
-
169.68
242.39%
80.20
52.73%
68.82
14.19%
43.41
36.92%
86.24
98.66%
92.29
7.01%
22.00
76.16%
94.45
329.23%
21.39
77.36%
days sales outstanding
85.83
-
179.00
108.54%
83.01
53.62%
85.29
2.74%
101.45
18.95%
84.14
17.06%
87.74
4.29%
84.50
3.69%
85.72
1.44%
80.96
5.56%
debt to assets
0.10
-
0.19
85.52%
0.31
62.35%
0.31
2.50%
0.22
27.58%
0.19
15.78%
0.22
17.90%
0.33
48.43%
0.35
7.13%
0.36
3.62%
debt to equity
0.14
-
0.30
113.51%
0.57
89.80%
0.51
9.85%
0.35
31.68%
0.26
25.28%
0.31
20.03%
0.55
75.92%
0.61
10.71%
0.65
6.13%
dividend yield
0.13
-
0.01
-
earnings yield
0.01
-
-0.01
204.85%
-0.01
61.82%
-0.00
86.04%
0.00
303.40%
0.00
11.41%
0.00
73.80%
-0.00
385.75%
-0.13
6,062.90%
-0.04
65.53%
enterprise value
197.82M
-
524.30M
165.04%
758.18M
44.61%
796.32M
5.03%
1.18B
48.45%
2.90B
145.20%
5.84B
101.32%
4.39B
24.79%
1.50B
65.93%
2.30B
53.78%
enterprise value over ebitda
89.19
-
149.50
67.63%
25.92
82.66%
32.30
24.62%
37.19
15.12%
75.00
101.67%
173.72
131.63%
101.23
41.73%
-17.83
117.61%
-352.79
1,878.94%
ev to operating cash flow
20.93
-
82.01
291.78%
35.30
56.95%
44.15
25.06%
26.40
40.21%
124.04
369.92%
4.00K
3,122.32%
-164.24
104.11%
-22.66
86.20%
-1.18K
5,096.35%
ev to sales
2.27
-
5.25
131.23%
3.11
40.87%
3.08
0.87%
4.27
38.72%
7.09
65.98%
13.13
85.18%
9.06
30.98%
2.93
67.62%
3.89
32.49%
free cash flow per share
0.11
-
0.07
34.98%
0.18
160.45%
0.05
69.56%
0.36
550.38%
0.03
90.66%
-0.25
865.63%
-0.76
197.59%
-0.78
2.97%
-0.24
68.63%
free cash flow yield
0.03
-
0.01
65.55%
0.02
139.18%
0.01
70.55%
0.03
356.97%
0.00
95.97%
-0.00
515.95%
-0.02
369.59%
-0.08
280.24%
-0.02
82.09%
graham net net
0.55
-
-1.11
300.14%
-1.20
8.36%
-0.96
20.49%
-1.32
37.75%
0.49
136.89%
0.89
84.14%
-1.25
240.09%
-1.63
29.84%
-1.71
4.80%
graham number
0.73
-
1.93
162.54%
2.00
3.82%
0.79
60.61%
1.61
104.62%
3.01
86.74%
2.35
21.86%
3.80
61.75%
14.49
280.98%
10.88
24.93%
income quality
8.35
-
-2.52
130.21%
-3.75
48.81%
-21.32
468.13%
16.96
179.57%
2.92
82.79%
0.35
88.01%
3.20
814.84%
0.46
85.71%
0.02
95.15%
intangibles to total assets
0.09
-
0.64
622.98%
0.66
4.42%
0.64
3.08%
0.67
3.87%
0.46
31.49%
0.34
26.78%
0.52
54.47%
0.54
3.20%
0.53
0.41%
interest coverage
2.39
-
-6.60
376.37%
0.26
103.90%
0.61
137.12%
1.61
163.99%
2.26
39.98%
-0.30
113.46%
-1.97
547.67%
-101.66
5,070.22%
-15.60
84.66%
interest debt per share
0.18
-
1.19
578.30%
1.50
25.53%
1.40
6.74%
1.38
0.91%
1.36
1.80%
2.07
52.59%
5.15
148.28%
4.93
4.28%
4.93
0.03%
inventory turnover
17.72
-
10.97
38.08%
21.38
94.88%
18.50
13.46%
17.28
6.61%
14.72
14.84%
8.76
40.50%
12.71
45.10%
13.26
4.33%
14.37
8.37%
invested capital
0.14
-
0.30
113.51%
0.57
89.80%
0.51
9.85%
0.35
31.68%
0.26
25.28%
0.31
20.03%
0.55
75.92%
0.61
10.71%
0.65
6.13%
market cap
223.02M
-
476.34M
113.58%
664.53M
39.51%
703.71M
5.90%
1.08B
53.42%
2.94B
172.20%
5.85B
98.92%
4.09B
29.98%
1.15B
71.96%
2.03B
76.92%
net current asset value
38.04M
-
-30.82M
181.00%
-71.70M
132.67%
-52.84M
26.30%
-80.90M
53.10%
88.64M
209.56%
154.69M
74.52%
-79.99M
151.71%
-136.72M
70.91%
-142.88M
4.51%
net debt to ebitda
-11.37
-
13.68
220.33%
3.20
76.59%
3.76
17.33%
3.22
14.17%
-1.04
132.21%
-0.31
69.94%
6.83
2,285.93%
-4.15
160.73%
-41.29
896.15%
net income per share
0.02
-
-0.04
297.88%
-0.07
76.22%
-0.01
85.57%
0.03
389.49%
0.08
158.43%
0.04
51.78%
-0.07
281.09%
-1.16
1,568.97%
-0.70
39.64%
operating cash flow per share
0.18
-
0.11
40.22%
0.28
162.22%
0.23
18.01%
0.52
130.34%
0.23
55.53%
0.01
94.22%
-0.22
1,756.66%
-0.53
138.49%
-0.02
97.07%
payables turnover
7.36
-
2.15
70.79%
4.55
111.56%
5.30
16.54%
8.41
58.53%
4.23
49.66%
3.95
6.55%
16.59
319.42%
3.86
76.70%
17.07
341.63%
receivables turnover
4.25
-
2.04
52.05%
4.40
115.63%
4.28
2.67%
3.60
15.93%
4.34
20.58%
4.16
4.11%
4.32
3.84%
4.26
1.42%
4.51
5.88%
research and ddevelopement to revenue
0.03
-
0.04
36.20%
0.02
54.72%
0.01
26.18%
0.01
22.87%
0.02
91.43%
0.02
10.81%
0.05
143.92%
0.06
31.74%
0.05
22.42%
return on tangible assets
0.02
-
-0.02
223.86%
-0.05
167.10%
-0.01
86.32%
0.02
328.13%
0.02
31.87%
0.01
69.50%
-0.01
245.91%
-0.18
1,823.26%
-0.11
37.18%
revenue per share
1.63
-
1.65
1.29%
3.15
90.90%
3.26
3.44%
3.23
0.73%
4.07
25.89%
4.09
0.59%
4.04
1.37%
4.10
1.64%
4.71
14.88%
roe
0.02
-
-0.01
156.81%
-0.03
188.09%
-0.00
86.58%
0.01
300.15%
0.02
91.52%
0.01
61.92%
-0.01
225.34%
-0.14
1,819.08%
-0.09
35.36%
roic
0.03
-
-0.01
139.61%
0.01
165.65%
0.00
60.95%
0.02
510.10%
0.03
73.90%
0.00
97.58%
-0.00
567.47%
-0.08
2,578.74%
-0.06
27.07%
sales general and administrative to revenue
0.27
-
0.34
23.24%
0.31
7.86%
0.34
10.54%
0.31
10.69%
0.31
2.14%
0.32
3.34%
0.46
41.26%
0.48
4.46%
0.41
13.94%
shareholders equity per share
1.13
-
3.93
248.32%
2.41
38.83%
2.59
7.54%
3.74
44.63%
5.05
34.94%
6.39
26.61%
9.24
44.48%
8.03
13.03%
7.50
6.63%
stock based compensation to revenue
0.01
-
0.03
338.60%
0.02
36.09%
0.02
11.79%
0.03
0.91%
0.02
2.67%
0.02
6.06%
0.05
101.81%
0.05
4.38%
0.04
13.98%
tangible asset value
53.26M
-
3.89M
92.69%
-37.49M
1,063.43%
-15.65M
58.25%
-17.48M
11.67%
182.17M
1,142.26%
362.56M
99.03%
138.84M
61.71%
67.00M
51.74%
45.64M
31.87%
tangible book value per share
1.00
-
0.06
93.54%
-0.48
852.01%
-0.20
59.24%
-0.20
3.60%
1.81
988.19%
3.34
84.16%
1.16
65.34%
0.54
53.40%
0.36
32.57%
working capital
44.12M
-
58.97M
33.66%
18.91M
67.93%
49.90M
163.83%
42.74M
14.34%
226.83M
430.69%
375.55M
65.56%
594.28M
58.24%
515.36M
13.28%
500.51M
2.88%

All numbers in USD (except ratios and percentages)